Company patents
UV Partners, Inc.
UV Partners, Inc. exhibits a highly concentrated patent strategy, with 100.0% of its portfolio in "Sterilization & Biocompatible Materials," which saw a significant 37.5% YoY growth in 2024 but a sharp decline of 90.9% so far in 2026, suggesting a potential shift in focus. Surprisingly, despite its medical device core, the company also explored "Healthcare Informatics" with a 300.0% YoY growth in 2024, though this also declined by 50.0% in 2025 and ceased in 2026, indicating a quickly abandoned or deprioritized area.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
31 US filings (since 2023) · 6 categories · 4 themes
Methods and apparatus for disinfecting or sterilizing medical devices, waste, or environments, often employing radiation, chemical agents, or thermal processes, and including monitoring systems.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Design and functionality of external components, peripherals, and mounting solutions that enhance, protect, or integrate with mobile electronic devices, such as modular cases, docking stations, and specialized mounts.
Systems and materials designed for purifying biological fluids (like blood) or capturing airborne particles (like respiratory droplets) using membranes, filters, or specialized coatings.
Patents
Showing 1-7 of 7
Mobile Device Accessories & Integration